White House Withdraws Heidi Overton’s Nomination to Lead the FDA a Day Before a Senate Committee Vote

The White House dropped Heidi Overton's nomination for Food and Drug Administration commissioner on Tuesday night, a day before a Senate committee vote. Acting Commissioner Kyle Diamantas, the agency's former food chief, keeps leading the FDA.

The White House withdrew Heidi Overton’s nomination to lead the U.S. Food and Drug Administration (FDA) on Tuesday night, Nov. 17, a day before the Senate Health, Education, Labor and Pensions (HELP) Committee was set to vote on it, NBC News and MS NOW reported. A White House official confirmed the decision. Axios first reported it.

TLDR

  • Overton, a preventive medicine doctor and White House domestic policy official, was nominated in August.
  • She needed 11 votes on the 21-member committee and could not lose a single Republican if all Democrats opposed her, NBC News reported.
  • Kyle Diamantas, who previously ran FDA’s food program, has been acting commissioner since Marty Makary resigned in May.
  • No new nominee had been named as of Tuesday night.

Why the Nomination Stalled

HELP Committee Chairman Sen. Bill Cassidy, R-La., had questioned whether Overton had enough managerial experience, and he said last week that he and other Republicans on the committee were undecided, Food Safety News reported. Sen. Susan Collins of Maine said she had not taken a position, and Sen. Lisa Murkowski of Alaska declined to say how she would vote, NBC News reported.

Cassidy said the key issue was the White House’s resistance to demands from anti-abortion senators, who have pushed the administration to further restrict access to abortion pills, according to MS NOW. FDA is reviewing the safety of abortion pills. After the withdrawal, Cassidy wrote on X that he believed Overton had a viable path to confirmation.

Food Policy in the Mix

Some supporters of Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) movement opposed Overton, arguing she would not push back hard enough on corporate interests, MS NOW reported. At her September hearing, senators also questioned her about FDA’s loosening of food safety regulations.

Who Runs FDA Now

Kyle Diamantas has led the agency as acting commissioner since May. Before that, he was FDA’s deputy commissioner for human foods. The agency has major food rules open, including a proposal to make GRAS (generally recognized as safe) notifications mandatory, with comments due Dec. 9, 2026.

Why It Matters

Democrats take control of the Senate in early January, which would make a new confirmation harder, NBC News reported. Semafor reported that the administration is considering Sen. Roger Marshall, R-Kan., a doctor on the HELP Committee who lost his re-election bid this month, according to MS NOW. Until a commissioner is confirmed, FDA’s food agenda stays under acting leadership.


Sources: NBC News (Berkeley Lovelace Jr. and Monica Alba, Nov. 17, 2026); MS NOW (Nov. 17, 2026); Food Safety News (Coral Beach, Nov. 17, 2026); Axios (Aug. 19, 2026); Federal Register, GRAS proposed rule.